Interestingly, their deficiency specifically suppresses PD-1 expression in CD8+ effector T cells without affecting CTLA-4 expression or the percentages of tumor-infiltrating CD4+Foxp3+ regulatory T cells (Tregs). The gene discussed is FOXP3; the disease is neoplasm.